Prevention of type 1 diabetes: what next?
Dunger
David B
DB
Department of Paediatrics and Institute of Metabolic Science, University of Cambridge, Cambridge CB2 OQQ, UK.
Todd
John A
JA
D001323:Autoantibodies / Q000235:genetics; D002675:Child, Preschool; D003922:Diabetes Mellitus, Type 1 / Q000235:genetics / Q000276:immunology* / Q000517:prevention & control*; D020022:Genetic Predisposition to Disease; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D007155:Immunologic Factors / Q000235:genetics; D007223:Infant; D007231:Infant, Newborn; D007328:Insulin / Q000008:administration & dosage / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic
D001323:Autoantibodies; D007004:Hypoglycemic Agents; D007155:Immunologic Factors; D007328:Insulin